Andreas Wagner Sells 21,118 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 21,118 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total transaction of $393,217.16. Following the transaction, the insider owned 148,687 shares of the company’s stock, valued at $2,768,551.94. This represents a 12.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock traded up $0.43 on Wednesday, reaching $18.88. The stock had a trading volume of 3,557,099 shares, compared to its average volume of 2,956,721. The business’s 50 day moving average is $20.96 and its two-hundred day moving average is $18.63. The company has a market cap of $3.86 billion, a P/E ratio of -1,886.11, a price-to-earnings-growth ratio of 3.12 and a beta of 1.18. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.10. The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.53%. Alignment Healthcare’s revenue for the quarter was up 44.4% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.16) earnings per share. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. TD Cowen raised their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a report on Friday, January 16th. KeyCorp reissued an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a research note on Thursday, January 22nd. JPMorgan Chase & Co. increased their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. Finally, Piper Sandler raised their price target on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.56.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Summit Securities Group LLC purchased a new position in shares of Alignment Healthcare in the fourth quarter worth approximately $26,000. Parallel Advisors LLC grew its position in shares of Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares in the last quarter. Larson Financial Group LLC purchased a new position in shares of Alignment Healthcare in the third quarter worth $33,000. First Horizon Corp bought a new position in shares of Alignment Healthcare during the 4th quarter valued at about $39,000. Finally, SBI Securities Co. Ltd. increased its stake in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares during the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.